Speaker illustration

Doctor Dike Bevis Ojji

University of Abuja, Abuja (Nigeria)

Dr. Dike Ojji had his basic medical education at Nigeria’s premier university, University of Ibadan, and subsequently had his postgraduate training in Internal Medicine and Cardiology at the University College Hospital, Ibadan and the Royal Brisbane and Women’s Hospital, Brisbane, Australia. He is a fellow of the West African College of Physicians, American College of Physicians, European Society of Cardiology and Nigerian Cardiac Society. He also holds a PhD in Cardiovascular Medicine from the University of Cape Town, South Africa. He is a faculty at College of Health Sciences of University of Abuja and an Honorary Consultant Physician/Cardiologist, at University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria. His areas of interest include pharmacotherapy of hypertension, spectrum of hypertensive heart disease, hypertensive heart failure in native Africans. He has over 66 manuscripts in peer reviewed journals including NEJM, JAMA, Lancet, Eur Heart J and Eur J Heart Fail.

How to reduce global CVD by 30% by 2030? Hypertension

Event: ESC Congress 2019

Topic: Prevention

Session: How to reduce global CVD by 30% by 2030?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb